Literature DB >> 12742588

Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania.

Kelly A Robinson1, Stephen M Beverley.   

Abstract

Approaches which eliminate mRNA expression directly are ideally suited for reverse genetics applications in eukaryotic microbes which are asexual diploids, such as the protozoan parasite Leishmania. RNA interference (RNAi) approaches have been successful in many species, including the related parasite Trypanosoma brucei. For RNAi tests in Leishmania, we developed improved protocols for transient and stable DNA transfection, attaining efficiencies of up to 25 and 3%, respectively. This facilitated RNAi tests at the alpha-tubulin locus, whose inhibition gives a strong lethal phenotype in trypanosomatids. However, transient or stable transfection of DNAs encoding mRNAs for an alpha-tubulin stem-loop construct and GFP to monitor transfection resulted in no effect on parasite morphology, growth or tubulin expression in Leishmania major or L. donovani. Transient transfection of a 24-nucleotide double-stranded alpha-tubulin siRNA also had no effect. Similar results were obtained in studies targeting an introduced GFP gene with a GFP stem-loop construct. These data suggest that typical RNAi strategies may not work effectively in Leishmania, and raise the possibility that Leishmania is naturally deficient for RNAi activity, like Saccharomyces cerevisae. The implications to parasite biology, gene amplification, and genetic analysis are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742588     DOI: 10.1016/s0166-6851(03)00079-3

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  126 in total

Review 1.  RNA interference: biology, mechanism, and applications.

Authors:  Neema Agrawal; P V N Dasaradhi; Asif Mohmmed; Pawan Malhotra; Raj K Bhatnagar; Sunil K Mukherjee
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

Review 2.  Repetitive elements in genomes of parasitic protozoa.

Authors:  Bill Wickstead; Klaus Ersfeld; Keith Gull
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

3.  Both sequence and context are important for flagellar targeting of a glucose transporter.

Authors:  Khoa D Tran; Dayana Rodriguez-Contreras; Ujwal Shinde; Scott M Landfear
Journal:  J Cell Sci       Date:  2012-03-30       Impact factor: 5.285

4.  Purine-responsive expression of the Leishmania donovani NT3 purine nucleobase transporter is mediated by a conserved RNA stem-loop.

Authors:  M Haley Licon; Phillip A Yates
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

5.  Double-stranded RNA reduces growth rates of the gut parasite Crithidia mellificae.

Authors:  Kleber de Sousa Pereira; Niels Piot; Guy Smagghe; Ivan Meeus
Journal:  Parasitol Res       Date:  2019-01-04       Impact factor: 2.289

6.  Protocols for gene silencing in schistosomes.

Authors:  David Ndegwa; Greice Krautz-Peterson; Patrick J Skelly
Journal:  Exp Parasitol       Date:  2007-08-15       Impact factor: 2.011

7.  A novel class of developmentally regulated noncoding RNAs in Leishmania.

Authors:  Carole Dumas; Conan Chow; Michaela Müller; Barbara Papadopoulou
Journal:  Eukaryot Cell       Date:  2006-10-27

8.  The role of the mitochondrial glycine cleavage complex in the metabolism and virulence of the protozoan parasite Leishmania major.

Authors:  David A Scott; Suzanne M Hickerson; Tim J Vickers; Stephen M Beverley
Journal:  J Biol Chem       Date:  2007-11-02       Impact factor: 5.157

9.  Two novel nucleobase/pentamidine transporters from Trypanosoma brucei.

Authors:  Diana Ortiz; Marco A Sanchez; Paula Quecke; Scott M Landfear
Journal:  Mol Biochem Parasitol       Date:  2008-10-17       Impact factor: 1.759

10.  The co-chaperone SGT of Leishmania donovani is essential for the parasite's viability.

Authors:  Gabi Ommen; Mareike Chrobak; Joachim Clos
Journal:  Cell Stress Chaperones       Date:  2009-12-02       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.